Universities, hospitals and research institutions across the United States are recruiting participants for clinical trials involving marijuana and cannabinoids, with studies examining their potential effects on chronic pain, cancer-related symptoms, epilepsy, autism, sleep and numerous other conditions.
The research involves several cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabigerol (CBG). Some studies are testing potential medical treatments, while others are examining how marijuana affects cognition, behavior and physiological responses.
The 29 studies below were identified through university research websites, institutional recruitment announcements and ClinicalTrials.gov. Each was listed as recruiting or advertised by its institution as accepting enrollment inquiries as of October 27, 2026. The list includes key eligibility requirements and direct links, phone numbers or email addresses for those interested in participating.
University of Colorado Boulder: CBD and THC for Cancer-Related Symptoms
Researchers at the University of Colorado Boulder are conducting a clinical trial examining whether hemp-derived CBD, either alone or combined with small amounts of THC, can improve sleep, pain, mood and quality of life among people with cancer.
The study plans to enroll 185 participants who will receive one of three treatments for eight weeks: CBD, CBD containing THC or a placebo.
Eligibility: Participants must be at least 25 years old, have a solid-tumor cancer diagnosis, be receiving treatment or have received treatment during the previous 18 months, and experience pain, sleep problems or mood-related symptoms. Regular marijuana users generally are not eligible.
How to apply: Call 720-808-1123 or email arctic.custudy@gmail.com. Additional information is available on the University of Colorado’s research page.
Yale University: THC and CBD for Chronic Pain and Opioid Use Disorder
Yale University is recruiting participants for a phase 2 trial examining whether THC and CBD can reduce chronic pain and opioid cravings among people receiving methadone treatment.
The study will enroll approximately 147 participants and administer different cannabinoid combinations during controlled laboratory sessions.
Eligibility: Applicants must be between 18 and 65 years old, have opioid use disorder and high-impact noncancer lower back pain lasting at least three months, and be receiving stable methadone treatment.
How to apply: Call 203-932-5711 or email julia.meyerovich@yale.edu. Another contact is 203-623-7493 or joao.deaquinolima@yale.edu.
The study is being conducted at the Connecticut Mental Health Center in New Haven.
University of California, San Diego: Vaporized Marijuana for Chronic Lower Back Pain
UC San Diego is recruiting adults for a study examining how vaporized marijuana containing THC affects pain processing and brain activity in people experiencing chronic lower back pain.
Participants undergo pain assessments and functional MRI imaging to evaluate changes in brain activity following marijuana or placebo administration.
Eligibility: Applicants must be 21 to 65 years old, have experienced lower back pain for at least three months, have used THC-containing marijuana within the previous two years and be willing to abstain from marijuana before participation. Current opioid use is among the exclusions.
How to apply: Complete the “Please contact me about this study” form on the UC San Diego recruitment page. The research team can also be contacted at 619-431-1850 or mameredith@health.ucsd.edu.
U.S. Department of Veterans Affairs: THC and CBD for Chronic Neuropathic Pain
The Department of Veterans Affairs is recruiting veterans for a multicenter clinical trial examining whether THC, CBD or combinations of the two can reduce chronic neuropathic pain.
The study plans to enroll approximately 320 participants, with recruiting locations in California, Connecticut, Rhode Island and Texas.
Eligibility: Applicants must be veterans at least 21 years old with persistent, high-impact neuropathic pain. Participants must satisfy medication and medical screening requirements and generally must refrain from marijuana use outside the study.
How to apply: Contact Courtney DiCocco at 203-932-5711 or Courtney.DiCocco@va.gov. The San Diego research site can also be contacted at 858-642-3029.
Johns Hopkins University: CBD for Tobacco Cessation
Johns Hopkins University is recruiting cigarette smokers for a clinical trial examining whether oral CBD can help people stop smoking tobacco.
Researchers are testing different doses of CBD against a placebo to examine whether the cannabinoid increases short-term smoking abstinence. The study lasts approximately six weeks and includes monitored practice attempts to quit smoking.
Eligibility: Applicants must be between 18 and 65 years old, currently smoke cigarettes and be interested in quitting. Additional medical and substance-use screening requirements apply.
How to apply: Complete the Johns Hopkins online screening questionnaire or call 410-550-5143.
Johns Hopkins states that participants may receive up to $615 in compensation for completing the study.
Johns Hopkins University: Marijuana and Alcohol Impairment
Johns Hopkins University is recruiting participants for a clinical trial investigating how marijuana and alcohol affect impairment when consumed individually or together.
Participants complete laboratory sessions involving vaporized marijuana containing THC, placebo marijuana, alcohol and placebo beverages. Researchers measure cognitive performance, behavior and subjective effects.
Eligibility: Applicants must be at least 21 years old, be in generally good health, have used marijuana within the past three years, have experienced at least one episode of binge drinking during the past three months and have previously consumed marijuana and alcohol together.
How to apply: Visit the Johns Hopkins trial page and select the Clinical Trials Website Interest Form. Applicants can also call 410-550-0529 or email tspindle@jhmi.edu.
University of Colorado Anschutz: CBD and Marijuana Use Among Young Adults
The University of Colorado Anschutz Medical Campus is recruiting young adults for a study examining how CBD affects marijuana consumption, subjective effects, mood and cognitive performance.
Participants complete four visits over approximately 12 weeks, including assessments conducted through the university’s mobile pharmacology laboratory.
Eligibility: Applicants must be between 18 and 25 years old, regularly use marijuana and not currently be seeking to reduce or stop their marijuana use.
How to apply: Complete the university’s online eligibility questionnaire. The study is also listed on the Rocky Mountain Cannabis Research Center’s recruitment page.
University of Colorado Anschutz: CBD for Marijuana Concentrate Users
A separate University of Colorado study is investigating how CBD influences marijuana use, cravings and other effects among people who regularly consume cannabis concentrates.
Participants receive CBD or a placebo and complete four visits over approximately five weeks.
Eligibility: Applicants must be between 25 and 60 years old, regularly use marijuana concentrates and not currently be seeking to cut down or stop consumption.
How to apply: Complete the online screening questionnaire, also accessible through the university’s official recruitment page.
University of Colorado Boulder: CBD and THC for Adults 60 and Older
Researchers are recruiting older adults for the Quality of Life Aging Research Trial, known as QUARTz, which investigates how CBD and low-dose THC affect health and well-being.
Participants receive CBD alone, CBD containing small amounts of THC or hemp seed oil without cannabinoids. The study involves four visits over eight weeks.
Eligibility: Applicants must be at least 60 years old, currently take medication for pain, sleep or mood, and not regularly use marijuana.
How to apply: Complete the official university screening form.
Additional information is available through the Rocky Mountain Cannabis Research Center.
University of Colorado Anschutz: Full-Spectrum CBD and Alcohol Consumption
Researchers at the University of Colorado School of Medicine are conducting a phase 2 trial examining whether CBD affects drinking behavior among adults who regularly consume alcohol.
Approximately 150 participants will receive full-spectrum CBD containing small amounts of THC, broad-spectrum CBD without THC or a placebo for eight weeks.
Eligibility: Applicants must be 21 to 65 years old, regularly consume alcohol and have used both marijuana and CBD at least once during the previous year.
How to apply: Call 303-724-7179 or email hollis.karoly@cuanschutz.edu. Alternatively, contact 225-244-3429 or landon.tomb@cuanschutz.edu.
University of Kentucky: CBD and the Effects of Marijuana
The University of Kentucky is recruiting participants for a clinical trial examining how repeated CBD administration influences marijuana’s subjective effects and pain-related outcomes.
Participants take different doses of CBD or placebo over two-week periods and receive vaporized marijuana or placebo during controlled laboratory sessions.
Eligibility: Applicants must be between 18 and 55 years old, be generally healthy, have experience using marijuana and not currently be seeking treatment for marijuana use.
How to apply: Contact Paul Nuzzo at 859-323-0002 or pnuzz2@email.uky.edu. Interested applicants can also email hannah.harris@uky.edu.
The study is being conducted in Lexington, Kentucky.
Florida A&M University: CBD for Diabetic Peripheral Neuropathy
Florida A&M University, working with the Florida State University/Tallahassee Memorial HealthCare residency program, is recruiting participants for a pilot trial testing CBD formulations for painful diabetic peripheral neuropathy.
Researchers are comparing CBD preparations, including full-spectrum formulations, with placebo to examine changes in nerve pain and other symptoms.
Eligibility: Applicants must be approximately 40 to 70 years old, have Type 2 diabetes and experience mild to moderate painful peripheral neuropathy. Recent marijuana use and certain medical conditions may exclude participation.
How to apply: Contact Justin Lee at 850-431-4947 or Justin.Lee2@tmh.org. Another contact is Phillip Treadwell at 850-431-5714 or phillip.treadwell@tmh.org.
University of California, San Diego: CBD for Early Psychosis
UC San Diego is recruiting adolescents and young adults for a trial examining whether CBD can help individuals experiencing early psychosis or symptoms associated with an elevated risk of psychosis.
Participants receive CBD or a placebo for eight weeks while researchers measure psychiatric symptoms, cognition and related outcomes.
Eligibility: Applicants must be between 16 and 30 years old, meet the study’s criteria for recent-onset psychosis or attenuated psychosis syndrome, and satisfy medication and medical screening requirements.
How to apply: Submit the contact form at the bottom of the UC San Diego study page. Alternatively, contact the research team at 619-543-6445 or KCADENHEAD@UCSD.EDU.
University of California, San Diego: THC, CBD, HIV and Brain Inflammation
UC San Diego researchers are studying how cannabinoids influence the gut microbiome, inflammation and neurological functioning in adults with and without HIV.
The clinical trial involves controlled administration of THC and CBD, with researchers examining biological and cognitive outcomes.
Eligibility: Applicants generally must be 21 to 70 years old, have previously used marijuana and meet specific requirements regarding recent marijuana consumption. Participants with HIV must satisfy additional treatment and viral-suppression criteria.
How to apply: Complete the contact form on the UC San Diego recruitment page, or contact the study team at 619-543-5000 or hnrprecruitment@ucsd.edu.
University of California, San Diego: CBD for Focal-Onset Seizures
UC San Diego is participating in a multicenter clinical trial examining whether prescription CBD oral solution can reduce focal-onset seizures in people with epilepsy.
The study, sponsored by Jazz Pharmaceuticals, is also enrolling participants at other medical institutions across the country.
Eligibility: Applicants must be between 12 and 75 years old, have a documented diagnosis of focal epilepsy and be receiving between one and four stable antiseizure medications. Recent use of prescription CBD or other marijuana products may exclude participation.
How to apply: Visit the UC San Diego clinical trial page and complete the contact form. Interested individuals may also contact the study sponsor at 215-832-3750 or ClinicalTrialDisclosure@JazzPharma.com.
University of California, San Francisco: Marijuana and Nicotine Co-Administration
UCSF is recruiting participants for a clinical study investigating how marijuana and tobacco or nicotine interact when consumed together.
Researchers examine the pharmacological and behavioral effects of THC and nicotine during controlled laboratory sessions.
Eligibility: Applicants generally must be 21 to 65 years old, have smoked or vaporized marijuana at least three days weekly over the preceding three months and regularly use inhaled nicotine products.
How to apply: Complete the contact form on the UCSF clinical trial recruitment page, or call 628-206-4226 or email armando.barraza@ucsf.edu.
Johns Hopkins University: Oral Marijuana Compounds and Their Effects
Johns Hopkins University is seeking healthy volunteers for a study examining the effects of orally administered compounds found in marijuana, including THC.
Participants complete six laboratory sessions lasting approximately nine hours each, along with an initial screening visit. The university advertises compensation of up to $2,330 for completing the study.
Eligibility: Applicants must be between 21 and 55 years old, be generally healthy and have a history of occasional marijuana use.
How to apply: Complete the official Johns Hopkins research interest form.
The university published a recruitment announcement on July 1, 2026.
Johns Hopkins University and Kennedy Krieger Institute: CBD for Infants With Sturge-Weber Syndrome
Johns Hopkins University and the Kennedy Krieger Institute in Baltimore are recruiting infants for a clinical trial examining whether prescription CBD can be administered safely before seizures begin in children with Sturge-Weber syndrome.
Researchers are investigating the feasibility and safety of early treatment using Epidiolex.
Eligibility: Participants must be approximately 1 to 18 months old, have a confirmed diagnosis of Sturge-Weber syndrome with specified brain involvement and have no history of seizures.
How to apply: Contact 443-923-9172 or comi@kennedykrieger.org. Another contact is 443-923-9127 or keam@kennedykrieger.org.
University of California, Los Angeles: Oral THC and CBD Absorption
UCLA Health is recruiting participants for a study examining how THC and CBD are absorbed, processed and detected in the body following oral administration.
Researchers are assessing cannabinoid concentrations and responses following administration of different formulations.
Eligibility: Applicants must be between 21 and 55 years old, be generally healthy, have experience with marijuana and meet the study’s restrictions on frequency of use and other substances.
How to apply: Complete UCLA’s study-specific contact request form, or contact the research team at 310-206-9942 or zcooper@mednet.ucla.edu.
Houston Methodist: CBD for Pain Following Shoulder Surgery
Houston Methodist is recruiting adults for a clinical trial examining whether CBD can reduce pain and improve recovery following rotator cuff surgery.
Participants receive prescription CBD or a placebo, with researchers monitoring postoperative pain, medication use and recovery.
Eligibility: Applicants must be adults scheduled for qualifying rotator cuff repair surgery. Certain medications, liver conditions and recent marijuana use may affect eligibility.
How to apply: Contact Haley Goble at 713-441-3930 or hmgoble@houstonmethodist.org. Alternatively, call 346-238-0206 or email dnarmond@houstonmethodist.org.
Baylor College of Medicine: THC for Chronic Lower Back Pain
Researchers affiliated with Baylor College of Medicine are recruiting participants at the Michael E. DeBakey VA Medical Center in Houston for a clinical trial examining whether dronabinol, a pharmaceutical form of THC, can help relieve chronic lower back pain.
The trial will enroll approximately 75 participants receiving oral THC or a placebo over eight weeks.
Eligibility: Applicants must be between 18 and 64 years old, have experienced chronic lower back pain for at least three months and meet additional requirements related to pain severity and medication stability.
How to apply: Contact 713-791-1414, extension 226020, or email verrico@bcm.edu. An alternative contact is extension 226134 or avaughan@bcm.edu.
Brown University: THC-Dominant and CBD-Dominant Marijuana and Alcohol Consumption
Brown University is recruiting adults for a phase 2 clinical trial investigating whether different marijuana formulations influence subsequent alcohol consumption.
Researchers are comparing THC-dominant marijuana, CBD-dominant marijuana and placebo during laboratory sessions that also involve alcohol administration.
Eligibility: Applicants must be between 21 and 50 years old, regularly use marijuana and have a history of heavy episodic alcohol consumption. Participants must not currently be seeking treatment for their drinking.
How to apply: Contact Brown University at 401-863-6650 or Jane_Metrik@brown.edu.
Penn State Cancer Institute: CBG and CBD Oil for Chemotherapy-Related Nerve Pain
Penn State Cancer Institute is recruiting adults for a clinical trial investigating whether an oil containing CBG, CBD and small amounts of other cannabinoids can help patients experiencing chemotherapy-induced peripheral neuropathy.
Participants take the cannabinoid oil under the tongue twice daily for 12 weeks, with researchers monitoring safety, tolerability, numbness, tingling and pain.
Eligibility: Applicants must be at least 21 years old, have persistent neuropathy symptoms and have completed platinum-based chemotherapy for a qualifying gastrointestinal cancer within the previous two years.
How to apply: Call 717-531-5471 or email PSCI-CTO@pennstatehealth.psu.edu.
Johns Hopkins University: CBD for Nicotine Withdrawal and Stress
Johns Hopkins University is recruiting cigarette smokers for a clinical trial investigating whether CBD affects stress responses and nicotine withdrawal symptoms.
Participants receive different doses of CBD or a placebo during controlled laboratory sessions, with researchers measuring mood, physiological stress responses and withdrawal-related symptoms.
Eligibility: Applicants must be between 21 and 70 years old, smoke more than five cigarettes daily and have been smoking for more than two years. Participants generally must have regular nighttime sleep schedules and meet alcohol-consumption and medical screening requirements.
How to apply: Contact Lauren Brogdon at 410-550-6953 or lmorri20@jhmi.edu. Another contact is 410-550-4035 or dlee@jhmi.edu.
The Lundquist Institute at Harbor-UCLA Medical Center: CBD for Sanfilippo Syndrome
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is recruiting participants for a clinical trial investigating CBD as a potential treatment for neurological and behavioral symptoms associated with Sanfilippo syndrome.
Participants receive prescription CBD or a placebo during controlled treatment periods, with researchers evaluating behavior, mood, sleep and other outcomes.
Eligibility: Applicants must be at least four years old and have a genetically confirmed diagnosis of Sanfilippo syndrome. Additional requirements concern disease progression, prior treatments and recent marijuana use.
How to apply: Contact the research program at 310-357-9023 or adolfo.morales@lundquist.org.
The study takes place in Torrance, California.
City of Hope: CBD and THC for Chemotherapy-Induced Neuropathy
City of Hope is recruiting cancer survivors for a phase 2 clinical trial examining whether CBD, alone or combined with THC, can reduce chronic chemotherapy-induced peripheral neuropathy.
Researchers are comparing the cannabinoid treatments with a placebo, examining nerve pain, tingling, numbness and quality of life.
Eligibility: Applicants must be adults with qualifying breast, gynecological or gastrointestinal cancer histories and persistent chemotherapy-related neuropathy. Participants must meet additional requirements concerning cancer treatment history, general health and medication use.
The study has recruiting locations in Duarte and Irvine, California.
How to apply: Contact City of Hope at 949-671-4091 or richlee@coh.org.
Washington State University: Vaporized Marijuana, Cognition and Emotional Responses
Washington State University is recruiting adults for a clinical trial examining how vaporized THC affects cognition, memory, mood and emotional responses.
Participants attend laboratory sessions during which they receive either THC-containing marijuana or a placebo. Researchers examine memory, executive functioning and changes in emotional responses.
Eligibility: Applicants must be at least 21 years old, have used marijuana at least once weekly for a minimum of one year and typically consume it by inhalation. Participants must be willing to abstain before laboratory visits. Certain medical or psychiatric conditions can exclude participation.
How to apply: Contact 509-335-6448 or ryan.mclaughlin@wsu.edu. Another contact is 509-335-0681 or carrie.cuttler@wsu.edu.
The study is being conducted in Pullman, Washington.
Johns Hopkins University: CBD for Adults With Autism Spectrum Disorder
Johns Hopkins University is recruiting adults diagnosed with autism spectrum disorder for a clinical trial examining whether CBD can improve anxiety, mood disturbances, sleep problems and challenging behaviors.
The study lasts approximately 14 weeks, including six weeks of CBD administration, a one- to two-week period without study medication and six weeks of placebo treatment. Researchers evaluate changes in psychiatric symptoms, daily functioning, cognition and physical health.
Eligibility: Applicants must be at least 18 years old, have an autism spectrum disorder diagnosis and experience significant mood-related or behavioral symptoms that interfere with functioning or quality of life.
How to apply: Call 410-575-3267 or contact the study coordinator at 410-550-6207 or ewise11@jhmi.edu.
Additional information is available through the Johns Hopkins research volunteer recruitment page.
Johns Hopkins University: Marijuana Intoxication and Pregnenolone
Johns Hopkins University is recruiting volunteers for a phase 2 clinical trial examining whether pregnenolone can reduce or reverse the intoxicating effects of THC.
Participants receive THC-containing marijuana brownies and varying doses of pregnenolone or placebo during controlled laboratory sessions. Researchers measure cognitive, psychological and physiological responses.
Eligibility: Applicants must be between 18 and 65 years old, be generally healthy, have used marijuana during the previous three years and be willing to abstain before experimental sessions. Certain medical conditions and medication use can exclude participation.
How to apply: Contact 646-572-6959 or dwolins2@jhmi.edu. Interested individuals can also use the contact form available on the Johns Hopkins study page.
The study takes place at the Johns Hopkins Behavioral Pharmacology Research Unit in Baltimore.
Although the studies were listed as recruiting or accepting enrollment inquiries when reviewed, availability may change, and not everyone who meets the basic requirements will qualify. Interested individuals should contact the respective research teams for complete eligibility criteria and to confirm that applications remain open.










